General Western Blot Reagents
Abcam Tunicamycin, Protein glycosylation inhibitor, 50MG
MW 816.9 Da, Purity >98%. Nucleoside antibiotic that inhibits protein glycosylation. Inhibits GlcNAc phosphotransferase (GPT) and inhibits the transfer of N-acetylglucosamine-1-phosphate from UDP-N-acetylglucosamine to dolichol phosphate in the first step of glycoprotein synthesis. Inhibits N-linked glycosylation and blocks the formation of N-glycosidic protein-carbohydrate linkages. Active in vitro against Gram-positive bacteria, yeasts, fungi and viruses.
The product is subject to the following: Abcam Restricted Use Statement
Abcam DAPT, gamma-Secretase inhibitor, 10MG
MW 432.5 Da, Purity >99%. γ-Secretase inhibitor. Inhibits Notch signalling in vitro. Inhibits total Aβ and Aβ42 production in human primary cultures (IC₅₀ values are 115 and 200 nM, respectively) with no effect on APPα and APPβ levels. Blood-brain barrier permeable. 3D Growth matrix component and component of cerebral organoid differentiation media.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Z-YVAD-FMK, Irreversible caspase-1 inhibitor, 5MG
MW 630.7 Da, Purity >98%. Z-YVAD-FMK, Irreversible caspase-1 inhibitor. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam PMSF, protease inhibitor, 100G
MW 174.19 Da, Purity >98%. Non-specific protease inhibitor; binds key active site serine residue in serine proteases, acetylcholinesterases, and thiol proteases. Suitable for use in vitro; in the preparation of cell lysates, and in vivo where it has been shown to block anandamide (ab120429) metabolism. Able to rapidly cross the BBB.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Nitric Oxide Assay Kit (Flow Cytometry Red)
Nitric Oxide Assay Kit (Flow Cytometry Red)
The product is subject to the following: Abcam Restricted Use Statement
Abcam WY 14643, PPARalpha agonist, 50MG
MW 323.8 g/mol, Purity >99%. Selective PPARα agonist (EC₅₀ values are 0.63, 32 and >100 μM at PPARα, PPARγ and PPARδ receptors respectively). Able to reduce inflammatory responses in vivo and in vitro.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Asta x anthin, Antio x idant agent, 25MG
MW 596.8 Da, Purity >97%. Potent antioxidant agent. PPARα agonist and PPARγ antagonist. Free radical scavenger. Reduces oxidative stress. Induces apoptosis. Inhibits NF-κB. Shows anti-inflammatory, antihypertensive, cardioprotective, neuroprotective and antitumor effects in vivo. Orally active.
The product is subject to the following: Abcam Restricted Use Statement
Abcam ML-9, protein kinase inhibitor, 10MG
MW 361.3 Da, Purity >98%. Broad spectrum ATP-competitive protein kinase inhibitor (Ki values are 32, 4, and 54 μM for PKA, MLCK, and PKC respectively). Ca²+ channel blocker. Shows vasorelaxant effects in vivo. .
The product is subject to the following: Abcam Restricted Use Statement
Abcam ML-9, protein kinase inhibitor, 250MG
MW 361.3 Da, Purity >98%. Broad spectrum ATP-competitive protein kinase inhibitor (Ki values are 32, 4, and 54 μM for PKA, MLCK, and PKC respectively). Ca²+ channel blocker. Shows vasorelaxant effects in vivo. .
The product is subject to the following: Abcam Restricted Use Statement
Abcam trans-11-Methyl octadecenoate, 100MG
MW 296.5 Da, Purity >99%. Methyl ester of *trans*-11-octadecenoic acid. Possible insulinotropic effects. Use in lipid studies and as internal standard. See *trans*-11-octadecenoic acid (ab143923).
The product is subject to the following: Abcam Restricted Use Statement
Abcam Ponasterone A, Ecdysone analog, 5MG
MW 464.6 Da, Purity >95%. Ecdysone (ab142425) analog. Potent ecdysteroid activity inducer (EC₅₀ = 70 nM). Increases β-galactosidase expression levels similar to Muristerone A (ab144309). Induces ecdysone-inducible mammalian expression system in vivo..
The product is subject to the following: Abcam Restricted Use Statement
Abcam Coprostanol, Cholesterol derivative, 25MG
MW 388.7 Da, Purity >98%. Cholesterol (ab142501) derivative. Forms from bacterial biohydrogenation of cholesterol. Biomarker for vertebrate intestinal microbe populations in vivo. .
The product is subject to the following: Abcam Restricted Use Statement
Abcam RGD (Arg-Gly-Asp), sequence involved in cell adhesion, 10MG
MW 346.34 Da, Purity >95%. RGD (Arg-Gly-Asp), sequence involved in cell adhesion. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam cis-Resveratrol, Antio x idant agent, 10MG
MW 228.24 Da, Purity >98%. Antioxidant agent. NADPH oxidase inhibitor. Blocks ROS production. Resveratrol (ab120726) isomer. Inhibits canonical and non-canonical inflammasomes in macrophages. Shows anti-inflammatory and antiproliferative effects. Orally bioavailable.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Cell Invasion Assay Kit (Collagen I), 24 well, 8 ¿m
Cell Invasion Assay Kit (Collagen I), 24 well, 8 ¿m
The product is subject to the following: Abcam Restricted Use Statement